Kallikrein 5 antibody (N-Term)
Quick Overview for Kallikrein 5 antibody (N-Term) (ABIN634928)
Target
See all Kallikrein 5 (KLK5) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- KLK5 antibody was raised against the N terminal of KLK5
-
Purification
- Affinity purified
-
Immunogen
- KLK5 antibody was raised using the N terminal of KLK5 corresponding to a region with amino acids CDHPSNTVPSGSNQDLGAGAGEDARSDDSSSRIINGSDCDMHTQPWQAAL
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
KLK5 Blocking Peptide, (ABIN937048), is also available for use as a blocking control in assays to test for specificity of this KLK5 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KLK5 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Kallikrein 5 (KLK5)
-
Alternative Name
- KLK5
-
Background
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers.
-
Molecular Weight
- 25 kDa (MW of target protein)
-
Pathways
- Complement System, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-